Government ❯ Politics ❯ Regulatory Agencies

FDA

Drug Policy Marty Makary Drug Regulation Public Health Abortion Policy Leadership Changes Vaccine Approval Process Drug Advertising Reproductive Rights Drug Approval Commissioner Actions Leadership Issues Healthcare Regulation Drug Safety Decision Making Public Health Policy Resignation Food Safety Mifepristone E-Cigarette Regulation Tobacco Regulation

GOP Senators Press FDA on Illegal Online Abortion Pill Sales, Launch Probe of Mifepristone Makers

The push reflects growing demands for stricter oversight of online pill sales expanded through telehealth.

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Missouri, Kansas and Idaho Sue to Block FDA’s New Generic Mifepristone Approval, Curb Mail-Order Access

FDA Approves Second Generic Mifepristone as White House Cites Legal Obligation

FDA Escalates Crackdown on Drug Ads, Moves to Close ‘Adequate Provision’ Loophole